Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients?
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (3) , 77.e1-77.e7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 PatientsEuropean Urology, 2015
- Segunda resección transuretral y pronóstico del cáncer de vejiga no músculo-invasivo de alto grado en pacientes que no reciben bacilo de Calmette-GuérinActas Urológicas Españolas, 2014
- Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancerUrology Annals, 2014
- Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomyEuropean Journal of Cancer, 2013
- Analysis of the Absence of the Detrusor Muscle in Initial Transurethral Resected Specimens and the Presence of Residual Tumor TissueUrologia Internationalis, 2012
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator ExperienceEuropean Urology, 2010
- International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomyBJU International, 2010
- Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International CohortEuropean Urology, 2010
- Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring ModelJournal of Urology, 2009
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006